Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis
暂无分享,去创建一个
M. Molokhia | A. Cope | S. Norton | J. Galloway | M. Filková | T. Mant | D. Scott | J. Carvalho
[1] Mary Jordan Samuel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2015, Journal of the American Geriatrics Society.
[2] Danijela Gnjidic,et al. Reducing inappropriate polypharmacy: the process of deprescribing. , 2015, JAMA internal medicine.
[3] Bruce Guthrie,et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010 , 2015, BMC Medicine.
[4] Alessandra Marengoni,et al. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity , 2015, BMJ : British Medical Journal.
[5] Paul Gallagher,et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.
[6] R. Payne,et al. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. , 2014, British journal of clinical pharmacology.
[7] Jonathan Kay,et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) , 2013, Annals of the rheumatic diseases.
[8] Carol Coupland,et al. Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score , 2013, BMJ Open.
[9] E. Molden,et al. Severity and Management of Drug–Drug Interactions in Acute Geriatric Patients , 2013, Drugs & Aging.
[10] W. Dixon,et al. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population , 2012, Rheumatology.
[11] Xiaoyun Pan,et al. Chronic Condition Clusters and Polypharmacy among Adults , 2012, International journal of family medicine.
[12] D. Scott,et al. Co-morbidities in established rheumatoid arthritis. , 2011, Best practice & research. Clinical rheumatology.
[13] Florence T. Bourgeois,et al. Adverse drug events in the outpatient setting: an 11‐year national analysis , 2010, Pharmacoepidemiology and drug safety.
[14] Azeem Majeed,et al. Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009 , 2010, Journal of the Royal Society of Medicine.
[15] M. Hochberg,et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity , 2010, Annals of the rheumatic diseases.
[16] M. Pirmohamed,et al. Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes , 2009, PloS one.
[17] Mohsen Sadatsafavi,et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. , 2008, Arthritis and rheumatism.
[18] S. Gabriel. Why do people with rheumatoid arthritis still die prematurely? , 2008, Annals of the rheumatic diseases.
[19] P. Donnan,et al. Development and validation of a model for predicting emergency admissions over the next year (PEONY): a UK historical cohort study. , 2008, Archives of internal medicine.
[20] G. Kitas,et al. Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity. , 2007, Musculoskeletal care.
[21] Josip Car,et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 , 2007, BMC clinical pharmacology.
[22] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.
[23] I. Edwards,et al. Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.
[24] J. Hallas,et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention , 1990, Journal of internal medicine.
[25] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[26] Diane Lacaille,et al. A systematic review identifies valid comorbidity indices derived from administrative health data. , 2015, Journal of clinical epidemiology.
[27] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[28] A. Silman,et al. Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .